AbbVie submits application to FDA for Tavapadon for treatment of Parkinson's disease
If approved, tavapadon will enhance AbbVie's leadership in Parkinson's disease by providing patients with a once daily oral treatment option
If approved, tavapadon will enhance AbbVie's leadership in Parkinson's disease by providing patients with a once daily oral treatment option
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
The new site enables end-to-end production of viral vector gene therapies
Air Liquide will provide care for people living with respiratory diseases such as chronic obstructive pulmonary disease (COPD) and sleep apnea
BIL also holds an option to increase its equity stake by an additional 15%
Physician-led Pi Health has demonstrated capabilities to dramatically reduce clinical trial timelines and administrative burden, while increasing data quality
Relonchem receives marketing authorization for Moxonidine tablets
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Subscribe To Our Newsletter & Stay Updated